Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLOVIS-2: Clopidogrel Response by Genotype in Premature CAD
NCT00822666Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in coronary artery disease (CAD), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2008; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00822666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822666.